Crane Company (CR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 2024 sales rose 13% year-over-year to $597 million, with adjusted EPS up 34% to $1.38 and GAAP EPS up 39% to $1.33, driven by 6% core sales growth and strong Aerospace & Electronics and Process Flow Technologies performance.
Core orders increased 6% and backlog grew 10% year-over-year, led by Aerospace & Electronics.
Major acquisitions included Vian Enterprises and CryoWorks, supporting growth in aerospace, defense, and cryogenics.
Operations were impacted by Hurricane Helene and a typhoon, but insurance is expected to cover business interruption and recovery is underway.
Full-year adjusted EPS guidance raised to $5.05–$5.20, reflecting improved outlook and strong execution.
Financial highlights
Adjusted operating profit increased 35% year-over-year to $109M, with operating profit up 38% to $105M.
Adjusted EBITDA grew 35% to $121M, with margin up to 20.3%.
Q3 free cash flow was $75M; full-year free cash flow expected at the lower end of $255M–$275M due to working capital and insurance timing.
Cash at quarter-end was $258M; total debt $332M.
Q3 2024 operating margin was 17.6% (up 320bps); adjusted margin 18.3% (up 310bps).
Outlook and guidance
Full-year core sales growth expected at 5%–7%, with total sales growth at ~11% and 5% benefit from acquisitions.
Segment operating profit projected to grow 19% year-over-year; adjusted segment operating margin expected at ~20.8%.
Free cash flow conversion expected at the low end of $255M–$275M due to working capital and hurricane impacts.
Engineered Materials sales anticipated to decline mid-single digits, with lower operating profit and margin.
Adjusted tax rate revised to 22.5%.
Latest events from Crane Company
- Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026 - Q1 2025 saw strong sales and profit growth, record backlog, and reaffirmed EPS guidance.CR
Q1 202525 Dec 2025 - Proxy details director elections, auditor ratification, and performance-based executive pay.CR
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting with no fee required.CR
Proxy Filing1 Dec 2025 - Q2 sales up 9.2%, adjusted EPS up 24%, guidance raised, and major PSI acquisition announced.CR
Q2 20253 Nov 2025